Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults

Abstract Background Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoi...

Full description

Bibliographic Details
Main Authors: Bjørndal, Bodil, Strand, Elin, Gjerde, Jennifer, Bohov, Pavol, Svardal, Asbjørn, Diehl, Bernd WK, Innis, Sheila M, Berger, Alvin, Berge, Rolf K
Format: Other/Unknown Material
Language:English
Published: BioMed Central Ltd. 2014
Subjects:
Online Access:http://www.lipidworld.com/content/13/1/82
id ftbiomed:oai:biomedcentral.com:1476-511X-13-82
record_format openpolar
spelling ftbiomed:oai:biomedcentral.com:1476-511X-13-82 2023-05-15T15:17:23+02:00 Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults Bjørndal, Bodil Strand, Elin Gjerde, Jennifer Bohov, Pavol Svardal, Asbjørn Diehl, Bernd WK Innis, Sheila M Berger, Alvin Berge, Rolf K 2014-05-17 http://www.lipidworld.com/content/13/1/82 en eng BioMed Central Ltd. http://www.lipidworld.com/content/13/1/82 Copyright 2014 Bjørndal et al.; licensee BioMed Central Ltd. Herring roe Phospholipids Eicosapentaenoic acid Docosahexaenoic acid Omega-3 polyunsaturated fatty acids Glycemic control Choline Acylcarnitines Research 2014 ftbiomed 2014-06-01T04:11:52Z Abstract Background Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (DHA)-rich fish oil mixture, with a DHA:eicosapentaenoic acid (EPA) ratio of about 3:1, which is also rich in choline. In this pilot study, we determined if MOPL30 could favorably affect plasma lipid parameters and glucose tolerance in healthy young adults. Methods Twenty female and one male adults, between 22 and 26 years of age, participated in the study. Participants took encapsulated MOPL30, 2.4 g/d EPA + DHA, for 14 days, and completed a three-day weighed food record before and during the capsule intake. Plasma lipids and their fatty acid (FA) composition, plasma and red blood cell (RBC) phosphatidylcholine (PC) FA composition, acylcarnitines, choline, betaine and insulin were measured before and after supplementation (n = 21), and one and four weeks after discontinuation of supplementation (n = 14). An oral glucose tolerance test was performed before and after supplementation. Results Fasting plasma triacylglycerol and non-esterified fatty acids decreased and HDL-cholesterol increased after 14 days of MOPL30 intake (p < 0.05). The dietary records showed that PUFA intake prior to and during capsule intake was not different. Fasting plasma glucose was unchanged from before to after supplementation. However, during oral glucose tolerance testing, blood glucose at both 10 and 120 min was significantly lower after supplementation with MOPL30 compared to baseline measurements. Plasma free choline and betaine were increased, and the n-6/n-3 polyunsaturated (PUFA) ratio in plasma and RBC PC were decreased post-supplementation. Four weeks after discontinuation of MOPL30, most parameters had returned to baseline, but a delayed effect was observed on n-6 PUFAs. Conclusions Herring roe rich in PL improved the plasma lipid profile and glycemic control in young adults with an overall healthy lifestyle. Other/Unknown Material Arctic BioMed Central Arctic
institution Open Polar
collection BioMed Central
op_collection_id ftbiomed
language English
topic Herring roe
Phospholipids
Eicosapentaenoic acid
Docosahexaenoic acid
Omega-3 polyunsaturated fatty acids
Glycemic control
Choline
Acylcarnitines
spellingShingle Herring roe
Phospholipids
Eicosapentaenoic acid
Docosahexaenoic acid
Omega-3 polyunsaturated fatty acids
Glycemic control
Choline
Acylcarnitines
Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
topic_facet Herring roe
Phospholipids
Eicosapentaenoic acid
Docosahexaenoic acid
Omega-3 polyunsaturated fatty acids
Glycemic control
Choline
Acylcarnitines
description Abstract Background Herring roe is an underutilized source of n-3 polyunsaturated fatty acids (PUFAs) for human consumption with high phospholipid (PL) content. Studies have shown that PL may improve bioavailability of n-3 PUFAs. Arctic Nutrition’s herring roe product MOPL™30 is a PL: docosahexaenoic acid (DHA)-rich fish oil mixture, with a DHA:eicosapentaenoic acid (EPA) ratio of about 3:1, which is also rich in choline. In this pilot study, we determined if MOPL30 could favorably affect plasma lipid parameters and glucose tolerance in healthy young adults. Methods Twenty female and one male adults, between 22 and 26 years of age, participated in the study. Participants took encapsulated MOPL30, 2.4 g/d EPA + DHA, for 14 days, and completed a three-day weighed food record before and during the capsule intake. Plasma lipids and their fatty acid (FA) composition, plasma and red blood cell (RBC) phosphatidylcholine (PC) FA composition, acylcarnitines, choline, betaine and insulin were measured before and after supplementation (n = 21), and one and four weeks after discontinuation of supplementation (n = 14). An oral glucose tolerance test was performed before and after supplementation. Results Fasting plasma triacylglycerol and non-esterified fatty acids decreased and HDL-cholesterol increased after 14 days of MOPL30 intake (p < 0.05). The dietary records showed that PUFA intake prior to and during capsule intake was not different. Fasting plasma glucose was unchanged from before to after supplementation. However, during oral glucose tolerance testing, blood glucose at both 10 and 120 min was significantly lower after supplementation with MOPL30 compared to baseline measurements. Plasma free choline and betaine were increased, and the n-6/n-3 polyunsaturated (PUFA) ratio in plasma and RBC PC were decreased post-supplementation. Four weeks after discontinuation of MOPL30, most parameters had returned to baseline, but a delayed effect was observed on n-6 PUFAs. Conclusions Herring roe rich in PL improved the plasma lipid profile and glycemic control in young adults with an overall healthy lifestyle.
format Other/Unknown Material
author Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
author_facet Bjørndal, Bodil
Strand, Elin
Gjerde, Jennifer
Bohov, Pavol
Svardal, Asbjørn
Diehl, Bernd WK
Innis, Sheila M
Berger, Alvin
Berge, Rolf K
author_sort Bjørndal, Bodil
title Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_short Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_full Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_fullStr Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_full_unstemmed Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
title_sort phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults
publisher BioMed Central Ltd.
publishDate 2014
url http://www.lipidworld.com/content/13/1/82
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_relation http://www.lipidworld.com/content/13/1/82
op_rights Copyright 2014 Bjørndal et al.; licensee BioMed Central Ltd.
_version_ 1766347629753532416